Skip to content
Menu

Mizuho Maintains Outperform on LifeMD, Lowers Price Target to $6

Benzinga Newsdesk 1 week ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Mizuho analyst Steven Valiquette maintains LifeMD (NASDAQ:LFMD) with a Outperform and lowers the price target from $7 to $6.

Mizuho analyst Steven Valiquette maintains LifeMD (NASDAQ:LFMD) with a Outperform and lowers the price target from $7 to $6.

Read at benzinga.com

← All stock news